Hongyu Xie

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Endometrial Cancer

Prognostic Factors

Top Venues

Journal of gynecologic oncology

Journal of cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology (2023)
Yiqun Li, Wenjie Wang, Danyun Wang, Liuchao Zhang, Xizhi Wang, Jia He, Lei Cao, Kang Li, Hongyu Xie
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. Genes 13 (12) (2022)
Yiqun Li, Wenjie Wang, Danyun Wang, Liuchao Zhang, Xizhi Wang, Jia He, Lei Cao, Kang Li, Hongyu Xie
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. Genes 13 (12) (2022)
Yiqun Li, Wenjie Wang, Danyun Wang, Liuchao Zhang, Xizhi Wang, Jia He, Lei Cao, Kang Li, Hongyu Xie
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. Genes 13 (12) (2022)
Yiqun Li, Wenjie Wang, Danyun Wang, Liuchao Zhang, Xizhi Wang, Jia He, Lei Cao, Kang Li, Hongyu Xie
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. Genes 13 (12) (2022)
Hongyu Xie, Huan Xu, Yan Hou, Yuqing Cai, Zhiwei Rong, Wei Song, Wenjie Wang, Kang Li
Integrative prognostic subtype discovery in high-grade serous ovarian cancer. Journal of cellular biochemistry 120 (11) (2019)
Weiwei Zhao, Falin Zhao, Kai Yang, Yaxin Lu, Yuanyuan Zhang, Wenjie Wang, Hongyu Xie, Kui Deng, Chunyan Yang, Zhiwei Rong, Yan Hou, Kang Li
An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade. Journal of cellular biochemistry 120 (8) (2019)